Fendx Technologies, Inc. · CSE:FNDX
Fendx Technologies — Investor Presentation (April 2024)
21 slides from Fendx Technologies's investor presentation, Apr 14, 2024
Slide 1: Making Lives Safer Through Nanotechnology: Corporate Deck
Making Lives Safer Through NANOTECHNOLOGY K E E P I N G S U R FA C E S C L E A N C O R P O R AT E D E C K CSE: FNDX | OTCQB: FDXTF | FSE: E8D APRIL,2024
Slide 2: Forward-Looking Statement
Forward-Looking Statement This presentation contains certain forward-looking statements within the meaning of Canadian securities legislation, including with respect to: the plans of the Company; expectations regarding industry trends, including with respect to the antimicrobial surface and coating
Slide 3: Developing Innovative Nanocoatings to Protect Surfaces from Lethal Pathogens
DEVELOPING INNOVATIVE NANOCOATINGS TO PROTECT SURFACES FROM LETHAL PATHOGENS REPEL bacteria, viruses and liquids REDUCE spread of bacteria & viruses CSE: FNDX | OTCQB: FDXTF | FSE:E8D APRIL 2024 / 3
Slide 4: The Problem
The Problem Spread of pathogens is hard to control • Current disinfecting practices are not enough • Top 10 frequent causes of death in the U.S.1,2 • >98,000 of deaths costing >$28 Bn annually in U.S. 2, 3 • Most bacteria are resistant to antibiotics making them difficult to treat Sources: 1. Future
Slide 5: Surfaces Are a Major Source of Pathogens
Surfaces Are a Major Source of Pathogens >80% of common infections are transmitted by touch SPORTS & HEALTHCARE ENTERTAINMENT OFFICES TRANSPORTATION SCHOOLS DOORKNOBS, PUSHDOORS HANDRAILS, ESCALATOR HANDLES PUSH PLATES ELEVATOR BUTTONS IV POLES, BED POLES CSE: FNDX | OTCQB: FDXTF | FSE:E8D APRIL 202
Slide 6: Nanotechnology to Protect Surfaces
Nanotechnology* to Protected with Protect Surfaces Nano-Coating Provides immediate & continuous protection of surfaces reducing adhesion of bacteria and virus >98%1,2, 3 When a contaminated hand touches a Unprotected nano-coated protected surface, the contamination tends to stay on the hand and not
Slide 7: REPELWRAP Film
Adhesive backing to easily REPELWRAP™ Film apply to high touch surfaces Lead Product in Development to Protect High Touch Surfaces • Provides immediate & continuous protection of surfaces • Target markets: healthcare and other high-touch, high traffic venues (i.e., transportation, schools) • >98% re
Slide 8: REPELWRAP Film – How It’s Made
REPELWRAP™ Film – How It’s Made Inspired by the lotus leaf Plasma Treatment Nanoparticle & Fluoropolymer Deposition Deposition of nanoparticles and Thermal Shrinking fluoropolymers on plastic film and thermal shrinking Schematic diagram illustrating the manufacturing process of REPELWRAPTM film. CSE
Slide 9: REPELWRAP Film Path To Commercialization
REPELWRAP™ Film Path To Commercialization Nanocoating Scale-up with Commercial Prototype Beta-Testing Formulation Dunmore* Production REPELWRAP™ Film Anticipate commercial product end of 2024 in Canada * Dunmore International Corp. (“Dunmore”), a Steel Partners Holdings L.P. (NYSE:SPLP) operating co
Slide 10: Spray Nano-Coating
Spray Nano-Coating To Protect High Touch Surfaces • >98% reduction in adhesion of MRSA and Covid-19 like virus1 • >99% killing of residual MRSA and P. aeruginosa1 • Expected to be easier to apply and expand applications Schematic illustration demonstrating how scpray coating is applied. Nanocoating
Slide 11: REPELWRAP Film and Spray Competitive Landscape
REPELWRAP™ Film and Spray Competitive Landscape Metal- REPELWRAP™ Liquid Containing** and Film* Disinfectants Photo-Activated Films Surface repels bacteria, viruses, +++ - - blood and liquids Instantly effective +++ +++ + 24/7 protection +++ - +++ Does not promote bacterial resistance +++ + + * Base
Slide 12: Nano-Coated Catheters
Nano-Coated Catheters To Reduce Infections and Blood Clots • >96% reduction in attachment of E. coli after Estimated annual infections/clots & 48 hours of flow exposure medical costs in U.S. • >95% reduction in blood or fibrin networks after 24 hours of whole blood flow exposure Cases Cost Foley cat
Slide 13: Building A Robust Patent Portfolio
Building A Robust Patent Portfolio Protecting Licensed Nanotechnology Used to Develop Film, Spray and Catheter Coatings Family 1 - Film Coating: • Canada Patent Application Number 3142127, entitled OMNIPHOBIC SURFACES WITH HIERARCHICAL STRUCTURES, AND METHODS OF MAKING AND USES THEREOF • European Pa
Slide 14: Antimicrobial & Antiviral Nano-Coating Market Offers Significant Opportunity
Antimicrobial & Antiviral Nano-Coating Market Offers Significant Opportunity Global market estimated to reach US$1.3 billion in 20261. $1,400 $1.3B $1,200 $1,000 $800 $600 $400 $200 $0 2022 2023 2024 2025 2026 Sources: 1. Future Markets Technology Report, Advanced Microbial Coatings, 2021 CSE: FNDX
Slide 15: Capital Light Model
Capital Light Model Use of contract manufacturers when ready to produce final products Revenue through licensing milestones and royalties on net sales Maximize non-dilutive funding CSE: FNDX | OTCQB: FDXTF | FSE:E8D APRIL 2024 / 15
Slide 16: Growth Strategy
Growth Strategy • Explore additional uses of nanotechnology • Assess licensing/acquisition opportunities to expand product pipeline and intellectual property portfolio • REPELWRAP™ film product launch expansion to the U.S. and other global markets CSE: FNDX | OTCQB: FDXTF | FSE:E8D APRIL 2024 / 16
Slide 17: Proven Management Team
Proven Management Team Dr. Carolyn Myers MBA, PhD Andrea Mulder BPHE, MBA Rose Zanic CPA, CA President, CEO & Director COO CFO & Corporate Secretary • Principal of BioEnsemble LLC, assisting • Over 25 years of pharma/biotech • Over 25 years of capital markets and start-ups and small pharma companies
Slide 18: Board of Directors
Board of Directors Dr. Carolyn Myers MBA, PhD Stephen Randall CPA, CGA Pierre Soulard B.C.L., LLB, LLM President, CEO & Director Independent Board Member Independent Board Member & Audit Committee Chair • Principal of BioEnsemble LLC, • Former Chief Legal Officer of CoinSmart assisting start-ups and
Slide 19: Featured in the Media
Featured in the Media SHARE Monday Management Update openexchange.tv/monday-management-update-december-4th/fendx-technologies- cse-fndx?category=1297&r=f “The healthcare world needs innovative solutions like these to contribute to Nasdaq Interview the global efforts to reduce the spread of potential
Slide 20: Key Highlights
Unique Disruptive Nanotechnology Award-winning, patent pending nanotechnology with instant repelling properties against microbes and liquids Global Need for Innovative Products to Keep Surfaces Clean Current practices are not sufficient and infection rates continue to increase Key Highlights Acceler
Slide 21: Thank You!
Thank You! Reach out with any questions investor@fendxtech.com / fendxtech.com CSE: FNDX | OTCQB: FDXTF | FSE:E8D APRIL 2024 / 21
Fendx Technologies — Investor Presentation (April 2024) on 6ix